These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28771616)

  • 1. Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype.
    Sharon E; Shi H; Kharbanda S; Koh W; Martin LR; Khush KK; Valantine H; Pritchard JK; De Vlaminck I
    PLoS Comput Biol; 2017 Aug; 13(8):e1005629. PubMed ID: 28771616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.
    Grskovic M; Hiller DJ; Eubank LA; Sninsky JJ; Christopherson C; Collins JP; Thompson K; Song M; Wang YS; Ross D; Nelles MJ; Yee JP; Wilber JC; Crespo-Leiro MG; Scott SL; Woodward RN
    J Mol Diagn; 2016 Nov; 18(6):890-902. PubMed ID: 27727019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients.
    Casas S; Tangprasertchai NS; Oikonomaki K; Mathers S; Sollet ZC; Samara S; Liu J; Burlinson ND; Constantoulakis P; Villard J; Viard T
    HLA; 2024 May; 103(5):e15518. PubMed ID: 38733247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
    Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
    Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients.
    Altuğ Y; Liang N; Ram R; Ravi H; Ahmed E; Brevnov M; Swenerton RK; Zimmermann B; Malhotra M; Demko ZP; Billings PR; Ryan A
    Transplantation; 2019 Dec; 103(12):2657-2665. PubMed ID: 30801536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Algorithm Measuring Donor Cell-Free DNA in Plasma of Cellular and Solid Organ Transplant Recipients That Does Not Require Donor or Recipient Genotyping.
    Gordon PM; Khan A; Sajid U; Chang N; Suresh V; Dimnik L; Lamont RE; Parboosingh JS; Martin SR; Pon RT; Weatherhead J; Wegener S; Isaac D; Greenway SC
    Front Cardiovasc Med; 2016; 3():33. PubMed ID: 27713880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability.
    North PE; Ziegler E; Mahnke DK; Stamm KD; Thomm A; Daft P; Goetsch M; Liang HL; Baker MA; Vepraskas A; Rosenau C; Dasgupta M; Simpson P; Mitchell ME; Tomita-Mitchell A
    PLoS One; 2020; 15(1):e0227385. PubMed ID: 31929557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients.
    Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J
    JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients.
    Keller MB; Meda R; Fu S; Yu K; Jang MK; Charya A; Berry GJ; Marboe CC; Kong H; Luikart H; Ponor IL; Shah PD; Khush KK; Nathan SD; Agbor-Enoh S
    Am J Transplant; 2022 Oct; 22(10):2451-2457. PubMed ID: 35322546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
    Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
    J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.
    Levitsky J; Kandpal M; Guo K; Kleiboeker S; Sinha R; Abecassis M
    Am J Transplant; 2022 Feb; 22(2):532-540. PubMed ID: 34510731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients.
    Keller M; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Appl Lab Med; 2022 Jun; 7(4):901-909. PubMed ID: 35024828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
    Bu L; Gupta G; Pai A; Anand S; Stites E; Moinuddin I; Bowers V; Jain P; Axelrod DA; Weir MR; Wolf-Doty TK; Zeng J; Tian W; Qu K; Woodward R; Dholakia S; De Golovine A; Bromberg JS; Murad H; Alhamad T
    Kidney Int; 2022 Apr; 101(4):793-803. PubMed ID: 34953773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Free DNA in Pediatric Solid Organ Transplantation Using a New Detection Method of Separating Donor-Derived from Recipient Cell-Free DNA.
    Preka E; Ellershaw D; Chandler N; Ahlfors H; Spencer H; Chitty LS; Fenton MJ; Marks SD
    Clin Chem; 2020 Oct; 66(10):1300-1309. PubMed ID: 32882007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR.
    Sigdel TK; Archila FA; Constantin T; Prins SA; Liberto J; Damm I; Towfighi P; Navarro S; Kirkizlar E; Demko ZP; Ryan A; Sigurjonsson S; Sarwal RD; Hseish SC; Chan-On C; Zimmermann B; Billings PR; Moshkevich S; Sarwal MM
    J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30583588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population.
    Kumar N; Tandon A; Rana R; Rana DS; Bhalla AK; Gupta A; Sachdeva MP; Huirem RS; Chauhan K; Yashavarddhan MH; Basnal A; Gupta R; Mallick PK; Ganguly NK
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal variance of Donor-Derived Cell-Free DNA (dd-cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables.
    Anand S; Lopez-Verdugo F; Sanchez-Garcia J; Dong L; Fife M; Krong J; Morris D; Srinivas TR
    Clin Transplant; 2021 Sep; 35(9):e14395. PubMed ID: 34165192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.